BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Rain Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 5:13 pm Sale | 2024-01-25 | 13D | Rain Therapeutics Inc. RAIN | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,526,729 (Position Closed) | Filing |
| 2023-12-18 4:35 pm Unchanged | 2023-12-13 | 13D | Rain Therapeutics Inc. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.800% | 0 (Unchanged) | Filing |
| 2023-08-17 4:52 pm Unchanged | 2023-08-10 | 13D | Rain Therapeutics Inc. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.800% | 0 (Unchanged) | Filing |
| 2022-11-10 4:51 pm Unchanged | 2022-11-08 | 13D | Rain Therapeutics Inc. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 14.200% | 0 (Unchanged) | Filing |
| 2022-01-11 5:13 pm Purchase | 2022-01-07 | 13D | Rain Therapeutics Inc. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 18.800% | 580,922 (+19.72%) | Filing |
| 2021-09-15 5:14 pm Purchase | 2021-09-13 | 13D | Rain Therapeutics Inc. RAIN | BIOTECHNOLOGY VALUE FUND L P | 2,945,807 15.700% | 400,554 (+15.74%) | Filing |
| 2021-07-06 5:16 pm Purchase | 2021-07-01 | 13D | Rain Therapeutics Inc. RAIN | BIOTECHNOLOGY VALUE FUND L P | 2,545,253 13.600% | 599,304 (+30.80%) | Filing |
| 2021-05-25 5:22 pm Purchase | 2021-05-21 | 13D | Rain Therapeutics Inc. RAIN | BIOTECHNOLOGY VALUE FUND L P | 1,945,949 13.000% | 93,438 (+5.04%) | Filing |
| 2021-04-28 09:26 am Purchase | 2021-04-23 | 13D | Rain Therapeutics Inc. RAIN | BIOTECHNOLOGY VALUE FUND L P | 1,852,511 13.000% | 1,852,511 (New Position) | Filing |